Aart Geus - Synopsys Co-Founder, Chairman and Co-CEO
| SNPS Stock | USD 565.07 7.13 1.28% |
Chairman
Dr. Aart J. de Geus is Chairman of the Board, CoChief Executive Officer of Synopsys Inc. Dr. de Geus cofounded Synopsys and has served as Chairman of our Board of Directors since February 1998 and Chief Executive Officer since January 1994. He has served as coChief Executive Officer with Dr. ChiFoon Chan since May 2012. Since the inception of Synopsys in December 1986, Dr. de Geus has held a variety of positions, including President, Senior Vice President of Engineering and Senior Vice President of Marketing. He has served as a director since 1986, and served as Chairman of our Board from 1986 to 1992 and again from 1998 until present. Dr. de Geus has also served on the board of directors of Applied Materials, Inc. since July 2007. since 2012.
| Age | 70 |
| Tenure | 12 years |
| Professional Marks | Ph.D |
| Address | 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 |
| Phone | 650-584-5000 |
| Web | https://www.synopsys.com |
Latest Insider Transactions
| 2024-07-15 | Disposed of 493 shares @ 620.6 | View | |
| 2024-07-10 | Disposed of 8648 shares @ 620.29 | View | |
| 2024-07-08 | Disposed of 5448 shares @ 620.95 | View | |
| 2024-07-05 | Disposed of 27753 shares @ 618.58 | View | |
| 2024-07-03 | Disposed of 2789 shares @ 610.94 | View | |
| 2024-07-01 | Disposed of 5893 shares @ 602 | View | |
| 2024-06-27 | Disposed of 8158 shares @ 602.59 | View | |
| 2024-06-25 | Disposed of 4212 shares @ 600.05 | View |
Synopsys Management Efficiency
The company has return on total asset (ROA) of 0.0862 % which means that it generated a profit of $0.0862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2182 %, meaning that it created $0.2182 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.20 in 2024, whereas Return On Capital Employed is likely to drop 0.15 in 2024. At this time, Synopsys' Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.67 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2024.Similar Executives
| Found 7 records | CHAIRMAN Age | ||
| Daniel Dines | Uipath Inc | 52 | |
| John Warnock | Adobe Systems Incorporated | 83 | |
| Matthew JD | Cloudflare | 49 | |
| Matthew Prince | Cloudflare | 49 | |
| Mark McLaughlin | Palo Alto Networks | 54 | |
| Jagtar Chaudhry | Zscaler | 65 | |
| Nikesh Arora | Palo Alto Networks | 52 | |
Management Performance
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0862 |
Synopsys Leadership Team
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sassine Ghazi, President CEO | ||
| Shankar Krishnamoorthy, Head Development | ||
| Paul Stravers, Principal Engineer | ||
| Shelagh Glaser, Chief Officer | ||
| Charlie Matar, Senior Group | ||
| John Koeter, Senior Strategy | ||
| John Runkel, General Counsel and Corporate Secretary | ||
| Joseph Logan, Executive VP of Sales and Corporate Marketing | ||
| Sudhindra Kankanwadi, Principal Accounting Officer, Vice President Corporate Controller | ||
| Trac Pham, Chief Officer | ||
| Deirdre Hanford, Chief Officer | ||
| Antonio Varas, Chief Officer | ||
| Michael Sanie, VP Communication | ||
| Erika McEnroe, Senior Counsel | ||
| Aart Geus, Co-Founder, Chairman and Co-CEO | ||
| Ann Minooka, Chief Officer | ||
| Lisa Ewbank, Vice President - Investor Relations | ||
| Alessandra Costa, Senior Group | ||
| Richard Mahoney, Chief Officer | ||
| Sriram Sitaraman, Senior Officer | ||
| Janet Collinson, HR Officer | ||
| Jill Larsen, Chief Officer | ||
| Jason Schmitt, General Group | ||
| Raja Tabet, Senior Group |
Synopsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synopsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0862 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 85.48 B | ||||
| Shares Outstanding | 153.61 M | ||||
| Shares Owned By Insiders | 0.40 % | ||||
| Shares Owned By Institutions | 93.90 % | ||||
| Number Of Shares Shorted | 2.61 M | ||||
| Price To Earning | 50.25 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.